Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Other ingredients with metabolic effects Several other compounds commonly included in GLP-1 support supplements show varying degrees of evidence
Generation I Semaglutide GLP-1 only Peak Weight Loss 14.9% STEP 1 trial 68 weeks Receptor Coverage Single GLP-1 FDA Status Approved (Wegovy, 2021) FIRST PUBLISHED Wilding et al., NEJM 2021 Generation II Tirzepatide GLP-1 + GIP Peak Weight Loss 22.5% SURMOUNT-1 trial 72 weeks Receptor Coverage Dual GLP-1, GIP FDA Status Approved (Zepbound, 2023) First Published Jastreboff et al., NEJM 2022 Generation III Retatrutide GLP-1 + GIP + GCGR Peak Weight Loss 24.2% Phase 2 48 weeks (highest dose) Receptor Coverage Triple GLP-1, GIP, GCGR FDA Status Phase 3 (TRIUMPH program) First Published Jastreboff et al., NEJM 2023 -SELECTED LITERATURE Key Retatrutide research and clinical publications
UV and visible light can degrade peptides over time
news outlets have documented millions of weight-loss drug prescriptions and the strain on insurers and patients
Promoting weight loss By targeting appetite regulation centers in the brain, retatrutide reduces hunger and increases feelings of fullness, leading to lower food intake
Hydration Support: Helps maintain moisture for soft, supple-looking skin
